Analyst Ratings for Morphic Therapeutic (MORF) [Neutrals]
MORF Rating Summary
MORF Price Target Summary
- Highest: $76.00 (RBC Capital)
- Lowest: $27.00 (Stifel)
- Average: $58.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$58.25 (+108.2%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Avg. $ Target:
$58.25 (+108.2%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/25/2023 | BTIG | Julian Harrison | Downgrade | Neutral (Buy) |
N/A (N/A) |
36.68 (27.98) |
-23.72% | Details |
| 8/9/2023 | Stifel » Updated 10/12/2023 |
Alex Thompson | Downgrade | Hold (Buy) |
27.00 (33.00) |
56.41 (27.98) |
-50.4% | Details |
